報價延遲最少15分鐘:2024/05/02 22:58 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.735 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.30/-0.30
|
|
企業價值
198.03M
|
| 資產負債 |
|
每股賬面淨值
1.48
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
27.46M
|
|
每股收益
0.40
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/05/02 22:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |